“Is the Neoadjuvant Docetaxel, Cisplatin and 5-Fluorouracil Regimen Superior to Classic Cisplatin and 5-Fluorouracil for Locoregionally Advanced Nasopharyngeal Carcinoma?”. Journal of Cancer Research Updates, vol. 2, no. 4, Nov. 2013, pp.  297-305, https://doi.org/10.6000/1929-2279.2013.02.04.8.